Skip to main content
Figure 7 | Molecular Medicine

Figure 7

From: miR-155 Modifies Inflammation, Endothelial Activation and Blood-Brain Barrier Dysfunction in Cerebral Malaria

Figure 7

Human umbilical vein endothelial cell (HUVEC) microvessels perfused with sera from children with cerebral malaria (CM) illustrate greater dextran leak versus sera control, which can be prevented with preincubation with miR-155 antagomir. (A) Bright field image of human sera perfused through the microvessels: normal pooled sera (left panel), CM sera (middle panel) and microvessels pretreated with antagomir-155 prior to CM sera (right panel) (scale bar: 100 µm). (B). Fluorescence image of microvessels perfused with 40 kDa dextran (as a marker of microvascular leak) after 5 min of perfusion, after different sera treatments. (C) Line cut of intensity profile of dextran-perfused microvessels in B at t = 1 min (blue line) and t = 5 min (red line). The permeability K of three conditions was determined to be 0.016 ± 0.005 µm/s (normal sera), 0.26 ± 0.13 µm/s (CM sera) and 0.065 ± 0.029 µm/s (antagomir-155 + CM sera). (D) Z-stack projection of confocal fluorescence images of microvessels after serum treatment and dextran perfusion, stained with CD31 (cell junction) and Hoechst 33342 (nuclei) (scale bar: 100 µm). Bottom panels: zoomed-in view of dashed square box (scale bar: 50 µm). Confocal images illustrate no differences in PECAM1/CD31 cell junctions despite significant differences in dextran leak. The assay was repeated with a different CM sample and yielded similar results (n = 2 biological replicates).

Back to article page